Two Distinct Mechanisms of Inhibition of LpxA Acyltransferase Essential for Lipopolysaccharide BiosynthesisJOURNAL OF THE AMERICAN CHEMICAL SOCIETYIF15.62020-02-1731PREAI
Design and Discovery of N-(3-(2-(2-Hydroxyethoxy)-6morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the ClinicJOURNAL OF MEDICINAL CHEMISTRYIF6.82019-05-0632OAAI
Pharmacological profile and anti-tumor properties of LXH254, a highly selective RAF kinase inhibitorCANCER RESEARCHIF16.62018-07-014PRE
Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-lmidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3JOURNAL OF MEDICINAL CHEMISTRYIF6.82017-10-1034PREAI
Design and Discovery of N-(2-Methyl-5′-morpholino-6′-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant CancersJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-06-0846PREAI
Discovery of Potent and Selective RSK Inhibitors as Biological ProbesJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-08-1352PREAI
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic MelanomaACS MEDICINAL CHEMISTRY LETTERSIF42015-08-0348OA
Inhibiting mutated KRAS, a broken switch of effector pathwaysMOLECULAR CANCER RESEARCHIF4.72015-02-050PRE
Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR InhibitorsACS MEDICINAL CHEMISTRY LETTERSIF42014-12-0124OAAI
Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors (vol 5, pg 989, 2014)ACS MEDICINAL CHEMISTRY LETTERSIF42014-11-250OAAI
Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase InhibitorsACS MEDICINAL CHEMISTRY LETTERSIF42014-07-1716OAAI
Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82008-10-2387PREAI